From ₹72 Lakh to ₹15,900: How India’s Supreme Court Just Made a ‘Death Sentence’ Disease Treatable
Historic Ruling Shatters Big Pharma’s Monopoly, Brings Hope to 5,000 Families Fighting Spinal Muscular Atrophy In a landmark decision that could redefine pharmaceutical access in India, the Supreme Court dismissed Swiss giant Roche’s final appeal, clearing the way for Hyderabad-based Natco Pharma to sell a generic version of Risdiplam—the only oral medication for Spinal Muscular […]










